Loading clinical trials...
Loading clinical trials...
To capture safety(FN) when IMF is administered to patients with extensive stage small cell lung cancer in clinical practice after launch
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AstraZeneca
NCT03212404 · Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, and more
NCT05566041 · Carcinoma, Small Cell Lung
NCT07476287 · Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ), and more
NCT03083691 · Carcinoma, Non-Small-Cell Lung, Carcinoma, Small Cell Lung
NCT00263731 · Carcinoma, Non-Small Cell Lung, Carcinoma, Small Cell Lung
Research Site
Chiba
Research Site
Fukuoka
Research Site
Gunma
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions